No black box warning on record for Idacio

As of the latest FDA labeling reviewed, Idacio (ADALIMUMAB-AACF) does not carry a black box warning. Standard warnings and precautions still apply — see the full Idacio medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections: Do not start IDACIO during an active infection. If an infection develops, monitor carefully, and stop IDACIO if infection becomes serious. ( 5.1 ) • Invasive fungal infections: For patients who develop a systemic illness on IDACIO, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. ( 5.1 ) • Mali

No black box warning on record for Idacio

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections: Do not start IDACIO during an active infection. If an infection develops, monitor carefully, and stop IDACIO if infection becomes serious. ( 5.1 ) • Invasive fungal infections: For patients who develop a systemic illness on IDACIO, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. ( 5.1 ) • Mali

Idacio Black Box Warning

No black box warning on record for Idacio

Other warnings & precautions

Idacio Black Box Warning

No black box warning on record for Idacio

Other warnings & precautions